Warning: count(): Parameter must be an array or an object that implements Countable in /home/logicben/public_html/drugtrialsformoney.com/wp-content/plugins/redux-framework/redux-core/inc/classes/class-redux-output.php on line 391

A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies

A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies
Conditions:   Advanced Malignant Neoplasm;   Breast Cancer;   Ovarian Cancer;   Homologous Recombination Deficiency
Interventions:   Drug: AMXI-5001:Dose Escalation Phase I;   Drug: AMXI-5001: Dose Expansion Phase II
Sponsor:   AtlasMedx, Incorporated
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

August 8, 2020 / by / in
Comments